ABCAM PLC-SPON ADR (ABCM)

US0003802040 - ADR

23.99  +0.01 (+0.04%)

After market: 23.99 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 7:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap5.49B
Shares
PE44.43
Fwd PE49.32
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABCM Daily chart

Company Profile

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Company Info

ABCAM PLC-SPON ADR

Discovery Drive, Cambridge Biomedical Campus, Hills Road

Cambridge CAMBRIDGESHIRE CB2 0AX

P: 441223696000.0

CEO: Alan Hirzel

Employees: 1750

Website: http://www.abcam.com/

ABCM News

News Image4 months ago - Danaher CorporationDanaher Completes Acquisition of Abcam

/PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The...

News Image4 months ago - Abcam plcAcquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales
News Image4 months ago - Seeking AlphaAbcam stock gains after securing all approves for Danaher sale, set to close Dec. 6

Abcam stock surged 3.7% as the company secured regulatory approvals for its $5.7 billion acquisition deal with Danaher.

News Image4 months ago - Seeking AlphaAbcam stock gains after securing all approvals for Danaher sale, set to close Dec. 6

Abcam stock surged 3.7% as the company secured regulatory approvals for its $5.7 billion acquisition deal with Danaher.

News Image4 months ago - Abcam plcAbcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023
News Image5 months ago - Seeking AlphaAbcam stock ticks higher amid report of China approval for sale to Danaher

China approves Danaher's $5.7 billion acquisition of Abcam, sending the stock up 0.6%.

ABCM Twits

Here you can normally see the latest stock twits on ABCM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example